Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Risk factors for mortality among hospitalized patients with COVID-19

A new study by scientists at biotechnology company Genentech, Inc., and published on the preprint server medRxiv in September 2020 attempts to identify the factors which may shape the risk for death in COVID-19 disease.

27 Sep 2020

CRISPR screening identifies human host pathways that facilitate coronavirus infection

The human coronavirus family consists of 7 known pathogens, for which there are no approved vaccines or specific therapeutic options. Although the seasonal human coronaviruses - OC43, HKU1, 229E, and NL63 – only cause mild respiratory infections, three highly pathogenic coronaviruses that emerged in the last two decades revealed the pandemic potential of this family of viruses.

27 Sep 2020

Young adults now driving force behind the ongoing COVID-19 pandemic says CDC

The Centers for Disease Control and Prevention (CDC) has released a report stating that the ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is on the rise among young adults and this rise is preventing the pandemic from abating.

27 Sep 2020

College re-openings could cause 3,200 extra cases of COVID-19 per day in the US

A new report published in the preprint server medRxiv in September 2020 shows the close relationship between the re-opening of colleges, especially those drawing students from high-incidence areas, and those offering in-person instruction, and the significant increase in the incidence of COVID-19 among students and the community.

27 Sep 2020

Bacteria-free method for making SARS-CoV-2 infectious clones

Using a circular polymerase chain reaction, researchers have developed a method for making severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant virus, with the ability to introduce mutations. The research by Japanese scientists is published on the preprint server bioRxiv* in September 2020.

27 Sep 2020

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.

27 Sep 2020

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

As we improve our understanding of immune responses and correlates of protection against the severe acute respiratory syndrome coronavirus (SARS-CoV-2), two UK researchers emphasize that we will probably utilize different assays to tackle specific questions. Their commentary is published in the prestigious journal Lancet Infectious Diseases.

27 Sep 2020

Criticisms of COVID-19 models appear to undermine public trust in science

Criticisms of COVID-19 models by Democratic elites in May 2020 appeared to undermine public support for the models' use - and trust in science more broadly - according to a series of survey experiments conducted with the participation of more than 6,000 Americans.

26 Sep 2020

Masks and face coverings are effective in reducing the spread of airborne particles

Laboratory tests of surgical and N95 masks by researchers at the University of California, Davis, show that they do cut down the amount of aerosolized particles emitted during breathing, talking and coughing.

26 Sep 2020

Yale designates three independent laboratories to perform SalivaDirect COVID-19 test

Yale has designated three independent laboratories to perform the university-developed SalivaDirectTM COVID-19 test.

26 Sep 2020

Combination of heat and high relative humidity can disinfect N95 mask materials

As the COVID-19 pandemic swept around the world early this year, shortages of protective equipment such as N95 masks left healthcare workers little choice but to reuse the masks they had - increasing the risk of infection for both them and their patients.

26 Sep 2020

Mask-wearing, handwashing, and social distancing protect against COVID-19, confirms study

A contact tracing study presented at this year's ESCMID Conference on Coronavirus Disease (ECCVID) confirms the effectiveness of wearing of masks in public, handwashing, and social distancing to protect against SARS-CoV-2 infection.

26 Sep 2020

Addressing the impact of COVID-19 pandemic on global mental health

In a special session addressing global mental health before, during and after the COVID-19 pandemic held at the ESCMID Conference on Coronavirus Disease (ECCVID) Professor Vikram Patel H(arvard Medical School, USA) will present a new review of the impact of the COVID-19 pandemic on global mental health.

26 Sep 2020

Shorter time from COVID-19 symptom onset to hospitalization linked to disease severity, death

New research presented at this week's ESCMID Conference on Coronavirus Disease (ECCVID, held online) shows that a shorter time from symptom onset to hospitalization is associated with more serious disease and death in patients with COVID-19.

26 Sep 2020

SARS-CoV-2 emergence linked with decrease in circulation of common respiratory viruses

Analysis of samples taken to test for respiratory viruses over the past five years suggests that the emergence of SARS-CoV-2 was associated with a large drop in circulation of other common respiratory viruses during the first wave.

26 Sep 2020

New trial tests combination antibody treatment for preventing COVID-19 illness

A combination antibody treatment for preventing COVID-19 illness in individuals who have had sustained exposure to someone with the virus is being studied by researchers at The University of Texas Health Science Center at Houston.

25 Sep 2020

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.

25 Sep 2020

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

As COVID-19 quickly spread worldwide this spring, shortages of supplies, including the nasopharyngeal (nasal) swabs used to collect viral samples, limited diagnostic testing.

25 Sep 2020

Ultrapotent antibody mix locks infection machinery, inhibits SARS-CoV-2 attachment to cells

A mix of ultrapotent antibodies from recovered COVID-19 patients has been shown to recognize and lock down the infection machinery of the pandemic coronavirus and keep it from entering cells. Each of the antibody types performs these overlapping tasks slightly differently.

25 Sep 2020

People with musculoskeletal pain report worsening symptoms during lockdown

People with bone, joint and muscle pain saw their symptoms worsen during lockdown - according to new research from the University of East Anglia.

25 Sep 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Risk factors for mortality among hospitalized patients with COVID-19

CRISPR screening identifies human host pathways that facilitate coronavirus infection

Young adults now driving force behind the ongoing COVID-19 pandemic says CDC

College re-openings could cause 3,200 extra cases of COVID-19 per day in the US

Bacteria-free method for making SARS-CoV-2 infectious clones

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

Criticisms of COVID-19 models appear to undermine public trust in science

Masks and face coverings are effective in reducing the spread of airborne particles

Yale designates three independent laboratories to perform SalivaDirect COVID-19 test

Combination of heat and high relative humidity can disinfect N95 mask materials

Mask-wearing, handwashing, and social distancing protect against COVID-19, confirms study

Addressing the impact of COVID-19 pandemic on global mental health

Shorter time from COVID-19 symptom onset to hospitalization linked to disease severity, death

SARS-CoV-2 emergence linked with decrease in circulation of common respiratory viruses

New trial tests combination antibody treatment for preventing COVID-19 illness

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

Ultrapotent antibody mix locks infection machinery, inhibits SARS-CoV-2 attachment to cells

People with musculoskeletal pain report worsening symptoms during lockdown

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in